Summary

The global biopsy devices market size reached US$ 2.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.8% during 2024-2032. The rising prevalence of cancer, increasing preference for personalized medicine, and the push toward minimally invasive procedures for patient comfort and quicker recovery times are some of the major factors propelling the market.

Biopsy devices are medical instruments specifically designed for extracting tissue samples from a patient's body for diagnostic purposes. They are widely used in various healthcare settings and are instrumental in diagnosing a wide range of conditions, including cancer, infections, and inflammatory diseases. They are available in different types, such as needle, forceps, and vacuum-assisted biopsy devices, each serving particular medical requirements. By employing real-time imaging techniques like ultrasound, CT scans, or MRI, healthcare professionals can pinpoint the exact location from which the tissue needs to be taken, thereby improving the procedure's success rate. As a result, biopsy devices have gained immense traction as indispensable tools in modern diagnostic medicine, facilitating precise and timely interventions.

The aging population, which is more susceptible to diseases requiring biopsy for diagnosis, will stimulate market growth during the forecast period. Additionally, the heightened focus on personalized medicine, which often necessitates multiple biopsy procedures to monitor the disease's progression and adapt the treatment plan accordingly, increases the frequency of biopsy device usage. In line with this, the global push toward minimally invasive procedures for patient comfort and quicker recovery times has accelerated the adoption of biopsy devices designed for these less intrusive techniques. Furthermore, the rising healthcare expenditure and supportive reimbursement policies in several countries are contributing to market growth. As governments and private insurers across the globe aim to provide better healthcare services, there is a higher likelihood of reimbursements for diagnostic procedures like biopsies, making them more accessible to patients fueling the market growth.

Biopsy Devices Market Trends/Drivers:
Rising Incidence of Cancer

The increasing burden of cancer worldwide is a significant driver for the biopsy devices market. Cancer diagnoses require precise and early-stage identification for optimal treatment, making biopsies an essential diagnostic tool. According to the World Health Organization, cancer is the second leading cause of death globally, responsible for an estimated 9.6 million deaths in 2018. As cancer rates continue to escalate, there has been a rise in the need for accurate and efficient diagnostic methods. Therefore, biopsy devices are becoming vital in identifying malignant tissues, allowing clinicians to formulate appropriate treatment plans. The rising incidence of cancer catalyzes the demand for advanced biopsy devices, thus positively influencing market growth.

Rapid Technological Advancements

Innovations in biopsy devices represent another major growth-inducing factor. Technological advancements are improving the efficacy, speed, and safety of biopsy procedures. For instance, vacuum-assisted biopsy devices allow quicker and more comfortable extraction of tissue samples, thereby enhancing patient experience. Additionally, the integration of real-time imaging techniques such as ultrasound, CT scans, or MRI with biopsy devices provides physicians with a more accurate target area, reducing procedural complications and increasing diagnostic reliability. Such technological enhancements contribute to higher product adoption rates among healthcare professionals, which in turn is propelling market growth.

Extensive Investments in Healthcare Infrastructure

The rising investments in healthcare infrastructure, especially in emerging economies, also drive the market toward growth. The increased funding by public and private agencies facilitates the modernization of medical facilities, including diagnostic labs and the acquisition of state-of-the-art medical equipment. As healthcare systems globally are focusing on delivering more accurate and timely diagnostics, the incorporation of advanced biopsy devices becomes a natural progression. This has expanded the market for these devices while ensuring broader access to high-quality diagnostic procedures for patients, thus providing a positive thrust to the market growth.

Biopsy Devices Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global biopsy devices market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on procedure type, product, application, guidance technique, and end user.

Breakup by Procedure Type:

Surgical Biopsy
Needle Biopsy

Surgical biopsy dominates the market

The report has provided a detailed breakup and analysis of the market based on the procedure type. This includes surgical biopsy and needle biopsy. According to the report, surgical biopsy represented the largest segment.

Surgical biopsy is widely preferred among healthcare professionals for accurate and comprehensive tissue analysis due to its high diagnostic accuracy and versatility. Unlike other biopsy methods, such as needle or liquid biopsies, surgical biopsies enable the removal of an entire tumor or a larger section of tissue, providing a more comprehensive sample for analysis. This increased sample size enhances the ability of pathologists to make accurate and definitive diagnoses, particularly in complex cases where malignancy is suspected but not confirmed through less invasive methods. Additionally, surgical biopsies are often employed in locations difficult to access by needle-based techniques, such as deeper tissues or organs. Another major contributing aspect is its utility beyond diagnosis; it often serves as both a diagnostic and therapeutic procedure by allowing for the complete excision of small malignant masses. The surgical approach is also favored in cases requiring immediate intervention or when other biopsy methods have yielded inconclusive results, thus supporting the segment growth.

Breakup by Product:

Biopsy Guidance Systems
Needle Based Biopsy Guns
Biopsy Needles
Biopsy Forceps
Others

Biopsy guidance systems represent the most popular product

A detailed breakup and analysis of the market based on the product has also been provided in the report. This includes biopsy guidance systems, needle based biopsy guns, biopsy needles, biopsy forceps, and others. According to the report, biopsy guidance systems accounted for the largest market share.

Biopsy guidance systems are crucial in enhancing the accuracy and efficiency of biopsy procedures. These guidance systems often integrate with imaging technologies like ultrasound, MRI, or CT scans to provide real-time visualization of the tissue area being targeted. Such integration allows healthcare professionals to precisely locate and assess the tissue sample needed for diagnosis, thereby reducing the risk of complications and procedural errors. In a medical landscape where precision is paramount, these guidance systems offer a significant edge. Their utility is especially prominent in complex cases where the targeted tissue is located deep within the body or near critical organs, where pinpoint accuracy is essential. Moreover, guidance systems are becoming increasingly user-friendly and compatible with various types of biopsy devices, which promotes their adoption across different healthcare settings. By facilitating quicker, more accurate, and safer procedures, biopsy guidance systems are indispensable tools that clinicians rely on, which is fueling the segment growth.

Breakup by Application:

Breast Biopsy
Lung Biopsy
Colorectal Biopsy
Prostate Biopsy
Others

Breast biopsy accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the application. This includes breast biopsy, lung biopsy, colorectal biopsy, prostate biopsy, and others. According to the report, breast biopsy represented the largest segment.

The main factor driving the growth of this segment is the high incidence of breast cancer globally. According to the World Cancer Research Fund, breast cancer is the most commonly occurring cancer in women and the second most common cancer overall. Early detection is critical for effective treatment, and biopsy remains one of the most reliable diagnostic methods for confirming the presence or absence of cancerous cells in breast tissue. Furthermore, advances in imaging technologies such as mammography and ultrasound have significantly improved the accuracy of breast biopsies, making it a preferred diagnostic option. Public awareness campaigns about the importance of early detection have also played a role in the frequent utilization of breast biopsy procedures. Increasingly, women are becoming proactive about their breast health, leading to more screenings and, subsequently, more biopsies to confirm or rule out malignancy. As a result, the breast biopsy segment continues to maintain its leading position in the biopsy devices market.

Breakup by Guidance Technique:

Ultrasound Guided Biopsy
Stereotactic Guided Biopsy
MRI Guided Biopsy
Others

Ultrasound guided biopsy holds the largest share in the market

A detailed breakup and analysis of the market based on the guidance technique has also been provided in the report. This includes ultrasound guided biopsy, stereotactic guided biopsy, MRI guided biopsy, and others. According to the report, ultrasound guided biopsy accounted for the largest market share.

Ultrasound-guided biopsy provides real-time imaging, allowing healthcare professionals to visualize the exact area from which the tissue sample is to be extracted. This enhances the accuracy and efficiency of the biopsy procedure. Moreover, ultrasound-guided biopsies are less invasive and generally quicker than other methods, requiring only local anesthesia. This further improves patient comfort and reduces recovery time. Compared to other imaging modalities like MRI or CT scans, ultrasound is considerably less expensive and more widely available across healthcare settings, including smaller clinics and outpatient centers. This accessibility makes it a go-to option for many physicians. Besides this, ultrasound does not involve exposure to ionizing radiation, making it a safer alternative for repeated procedures and specific patient populations, such as pregnant women. Due to these advantages—real-time imaging, cost-effectiveness, minimal invasiveness, and safety—ultrasound-guided biopsy is widely preferred, contributing to segment growth.

Breakup by End User:

Hospitals and Clinics
Academic and Research Institutes
Others

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals and clinics, academic and research institutes, and others.

Hospitals and clinics are often the first point of contact for patients requiring diagnostic procedures, including biopsies. These healthcare settings are equipped with advanced diagnostic tools and skilled professionals capable of performing a wide range of biopsy types. The growing incidence of diseases requiring biopsies, coupled with the expansion of healthcare infrastructure globally, has led to higher adoption of biopsy devices in these institutions. Moreover, hospitals often have the financial capacity to invest in the latest biopsy technologies, further augmenting the market growth.

Although smaller in market share compared to hospitals and clinics, academic and research institutes are an essential segment. These institutions primarily focus on research and development activities aimed at improving biopsy technologies or devising new diagnostic methods. They may also conduct clinical trials to evaluate the efficacy of new biopsy devices. While the volume of biopsies performed may be lower compared to hospitals, their influence on product innovation and validation is significant.

Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

North America exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share since the region has a high prevalence of lifestyle-related diseases, including cancer, necessitating frequent utilization of biopsy procedures for diagnosis and monitoring. According to the American Cancer Society, in 2021, an estimated 1.9 million new cancer cases were diagnosed in the United States alone. In addition, North America boasts a highly developed healthcare infrastructure, including hospitals and clinics equipped with advanced diagnostic technologies, thereby facilitating the adoption of state-of-the-art biopsy devices.

Apart from this, the region has significant investments in healthcare research and development, often leading the way in medical innovation, including the development of new and more effective biopsy techniques and devices. Furthermore, there is a strong insurance framework supporting medical procedures, including biopsies, which makes these diagnostic tests more accessible to a broader population. Also, high levels of public awareness about the importance of early diagnosis and preventive healthcare catalyze the demand for diagnostic procedures such as biopsies. These combined factors position North America as the leading regional market for biopsy devices.

Competitive Landscape:
The market is experiencing steady growth as key players are actively engaged in a range of strategic activities aimed at consolidating their market position. These actions include the development of technologically advanced devices, such as vacuum-assisted and image-guided biopsy systems, to increase accuracy and patient comfort. Companies are also focusing on mergers, acquisitions, and strategic collaborations to expand their product portfolios and geographic reach. Additionally, significant investment is being made in research and development (R&D) to innovate new products and improve existing ones. Regulatory approvals and patent filings are other critical areas of focus aimed at securing exclusivity for innovative devices. Through these combined efforts, key market players are shaping the trajectory of the biopsy devices industry.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Argon Medical Devices
Becton Dickinson and Company
Boston Scientific Corporation
Cardinal Health Inc.
CONMED Corporation
Cook Group Incorporated
Hologic Inc.
INRAD Inc.
Medtronic plc

Recent Developments:
In September 2023, Boston Scientific Corporation announced the U.S. Food and Drug Administration approval for the latest-generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure (LAAC) Device. Designed to advance further the procedural performance and safety of the WATCHMAN technology, which is indicated to reduce stroke risk in patients with non-valvular atrial fibrillation (NVAF) who need an alternative to oral anticoagulation therapy, the device now features a polymer coating, visualization markers, and a broader size matrix to treat a wider range of patients.
In August 2022, Mammotome, an operating company of Danaher Corporation, launched the Mammotome RevolveTM EX Dual Vacuum-Assisted Breast Biopsy System. It is the first vacuum-assisted biopsy device designed specifically for the excision of benign breast lesions and is twice as fast as traditional vacuum-assisted breast biopsy systems. This device is a minimally invasive solution and enables physicians to provide better care for patients with benign lesions by avoiding the risks and trauma of an open surgical procedure and creating little to no scarring.

Key Questions Answered in This Report:
How has the global biopsy devices market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global biopsy devices market?
What is the impact of each driver, restraint, and opportunity on the global biopsy devices market?
What are the key regional markets?
Which countries represent the most attractive biopsy devices market?
What is the breakup of the market based on the procedure type?
Which is the most attractive procedure type in the biopsy devices market?
What is the breakup of the market based on the product?
Which is the most attractive product in the biopsy devices market?
What is the breakup of the market based on the application?
Which is the most attractive application in the biopsy devices market?
What is the breakup of the market based on the guidance technique?
Which is the most attractive guidance technique in the biopsy devices market?
What is the breakup of the market based on the end-user?
Which is the most attractive end-user in the biopsy devices market?
What is the competitive structure of the global biopsy devices market?
Who are the key players/companies in the global biopsy devices market?

ページTOPに戻る

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Biopsy Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID 19
5.4 Market Forecast
6 Market Breakup by Procedure Type
6.1 Surgical Biopsy
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Needle Biopsy
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Product
7.1 Biopsy Guidance Systems
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Needle Based Biopsy Guns
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Biopsy Needles
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Biopsy Forceps
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Application
8.1 Breast Biopsy
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Lung Biopsy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Colorectal Biopsy
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Prostate Biopsy
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Guidance Technique
9.1 Ultrasound-guided Biopsy
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Stereotactic-guided Biopsy
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 MRI-guided Biopsy
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by End-User
10.1 Hospitals and Clinics
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Academic and Research Institutes
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Others
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Indicators
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Argon Medical Devices
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.2 Becton Dickinson and Company
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Boston Scientific Corporation
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 Cardinal Health Inc.
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 CONMED Corporation
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.6 Cook Group Incorporated
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7 Hologic Inc.
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 INRAD Inc.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.9 Medtronic plc
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 SWOT Analysis
List of Figures
Figure 1: Global: Biopsy Devices Market: Major Drivers and Challenges
Figure 2: Global: Biopsy Devices Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Biopsy Devices Market: Breakup by Procedure Type (in %), 2023
Figure 4: Global: Biopsy Devices Market: Breakup by Product (in %), 2023
Figure 5: Global: Biopsy Devices Market: Breakup by Application (in %), 2023
Figure 6: Global: Biopsy Devices Market: Breakup by Guidance Technique (in %), 2023
Figure 7: Global: Biopsy Devices Market: Breakup by End-User (in %), 2023
Figure 8: Global: Biopsy Devices Market: Breakup by Region (in %), 2023
Figure 9: Global: Biopsy Devices Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 10: Global: Biopsy Devices (Surgical Biopsy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Biopsy Devices (Surgical Biopsy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Biopsy Devices (Needle Biopsy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Biopsy Devices (Needle Biopsy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Biopsy Devices (Biopsy Guidance Systems) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Biopsy Devices (Biopsy Guidance Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Biopsy Devices (Needle Based Biopsy Guns) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Biopsy Devices (Needle Based Biopsy Guns) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Biopsy Devices (Biopsy Needles) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Biopsy Devices (Biopsy Needles) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Biopsy Devices (Biopsy Forceps) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Biopsy Devices (Biopsy Forceps) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Biopsy Devices (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Biopsy Devices (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Biopsy Devices (Breast Biopsy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Biopsy Devices (Breast Biopsy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Biopsy Devices (Lung Biopsy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Biopsy Devices (Lung Biopsy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Biopsy Devices (Colorectal Biopsy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Biopsy Devices (Colorectal Biopsy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Biopsy Devices (Prostate Biopsy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Biopsy Devices (Prostate Biopsy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Biopsy Devices (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Biopsy Devices (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Biopsy Devices (Ultrasound-guided Biopsy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Biopsy Devices (Ultrasound-guided Biopsy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: Biopsy Devices (Stereotactic-guided Biopsy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Biopsy Devices (Stereotactic-guided Biopsy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Global: Biopsy Devices (MRI-guided Biopsy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Global: Biopsy Devices (MRI-guided Biopsy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Global: Biopsy Devices (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Global: Biopsy Devices (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Global: Biopsy Devices (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Global: Biopsy Devices (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Global: Biopsy Devices (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Global: Biopsy Devices (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Global: Biopsy Devices (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Global: Biopsy Devices (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: North America: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: North America: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: United States: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: United States: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Canada: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Canada: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Asia Pacific: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Asia Pacific: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: China: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: China: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Japan: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Japan: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: India: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: India: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: South Korea: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: South Korea: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Australia: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Australia: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Indonesia: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Indonesia: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Others: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Others: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Europe: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Europe: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Germany: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Germany: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: France: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: France: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: United Kingdom: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: United Kingdom: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Italy: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Italy: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Spain: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Spain: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Russia: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Russia: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Others: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 85: Others: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Latin America: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 87: Latin America: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 88: Brazil: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 89: Brazil: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 90: Mexico: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 91: Mexico: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 92: Others: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 93: Others: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 94: Middle East and Africa: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 95: Middle East and Africa: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 96: Global: Biopsy Devices Industry: SWOT Analysis
Figure 97: Global: Biopsy Devices Industry: Value Chain Analysis
Figure 98: Global: Biopsy Devices Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Biopsy Devices Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Biopsy Devices Market Forecast: Breakup by Procedure Type (in Million US$), 2024-2032
Table 3: Global: Biopsy Devices Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 4: Global: Biopsy Devices Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: Biopsy Devices Market Forecast: Breakup by Guidance Technique (in Million US$), 2024-2032
Table 6: Global: Biopsy Devices Market Forecast: Breakup by End-User (in Million US$), 2024-2032
Table 7: Global: Biopsy Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 8: Global: Biopsy Devices Market: Competitive Structure
Table 9: Global: Biopsy Devices Market: Key Players